We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKC icon
376
McCormick & Company Non-Voting
MKC
$14B
$2.91M 0.02%
38,465
-6,012
-14% -$502K
AME icon
377
Ametek
AME
$53.9B
$2.9M 0.02%
19,617
-645
-3% -$101K
HSY icon
378
Hershey
HSY
$37.3B
$2.87M 0.02%
14,327
+14
+0.1% +$3.13K
MSI icon
379
Motorola Solutions
MSI
$72.1B
$2.86M 0.02%
10,510
-349
-3% -$99.4K
LI icon
380
Li Auto
LI
$14.4B
$2.85M 0.02%
80,000
-10,000
-11% -$394K
F icon
381
Ford
F
$60.9B
$2.85M 0.02%
229,363
-101,200
-31% -$1.31M
INBX
382
DELISTED
Inhibrx, Inc. Common Stock
INBX
$2.85M 0.02%
155,069
-32,000
-17% -$670K
ORLY icon
383
O'Reilly Automotive
ORLY
$75.1B
$2.84M 0.02%
46,890
-45,615
-49% -$2.86M
SONY icon
384
Sony
SONY
$137B
$2.84M 0.02%
172,345
HES
385
DELISTED
Hess
HES
$2.84M 0.02%
18,550
+639
+4% +$96.2K
PSA icon
386
Public Storage
PSA
$61.5B
$2.83M 0.02%
10,726
-20
-0.2% -$5.61K
AVB icon
387
AvalonBay Communities
AVB
$27.5B
$2.82M 0.02%
16,413
-620
-4% -$115K
GMED icon
388
Globus Medical
GMED
$11.1B
$2.81M 0.02%
56,631
-71,717
-56% -$4.01M
HAL icon
389
Halliburton
HAL
$26.1B
$2.8M 0.02%
69,167
-1,536
-2% -$60.2K
HIG icon
390
Hartford Financial Services
HIG
$39.9B
$2.77M 0.02%
39,132
-1,206
-3% -$87.5K
HAS icon
391
Hasbro
HAS
$13.5B
$2.77M 0.02%
41,888
-4,632
-10% -$307K
SWKS icon
392
Skyworks Solutions
SWKS
$9.2B
$2.77M 0.02%
28,047
+1,056
+4% +$112K
FAST icon
393
Fastenal
FAST
$54.8B
$2.75M 0.02%
100,774
-174
-0.2% -$4.94K
AFL icon
394
Aflac
AFL
$65.5B
$2.73M 0.02%
35,544
-4,572
-11% -$339K
ABNB icon
395
Airbnb
ABNB
$90.8B
$2.72M 0.02%
19,788
-280
-1% -$38.7K
VMW
396
DELISTED
VMware, Inc
VMW
$2.69M 0.02%
16,165
-1,487
-8% -$238K
FIS icon
397
Fidelity National Information Services
FIS
$24.2B
$2.65M 0.02%
47,903
-1,756
-4% -$101K
BKR icon
398
Baker Hughes
BKR
$58.3B
$2.64M 0.02%
74,638
-5,927
-7% -$210K
ADM icon
399
Archer Daniels Midland
ADM
$38.7B
$2.62M 0.02%
34,754
-23,482
-40% -$1.9M
TRU icon
400
TransUnion
TRU
$16B
$2.62M 0.02%
36,449

Similar funds

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.